Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods
- 1 May 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (5) , 1207-1212
- https://doi.org/10.1128/aac.42.5.1207
Abstract
This study was designed to examine the effects of antifungal carryover, agitation, and starting inoculum on the results of time-kill tests conducted with various Candida species. Two isolates each of Candida albicans , Candida tropicalis , and Candida glabrata were utilized. Test antifungal agents included fluconazole, amphotericin B, and LY303366. Time-kill tests were conducted in RPMI 1640 medium buffered with morpholinepropanesulfonic acid (MOPS) to a pH of 7.0 and incubated at 35°C. Prior to testing, the existence of antifungal carryover was evaluated at antifungal concentrations ranging from 1× to 16× MIC by four plating methods: direct plating of 10, 30, and 100 μl of test suspension and filtration of 30 μl of test suspension through a 0.45-μm-pore-size filter. Time-kill curves were performed with each isolate at drug concentrations equal to 2× MIC, using a starting inoculum of approximately 10 5 CFU/ml, and incubated with or without agitation. Last, inoculum experiments were conducted over three ranges of starting inocula: 5 × 10 2 to 1 × 10 4 , >1 × 10 4 to 1 × 10 6 , and >1 × 10 6 to 1 × 10 8 CFU/ml. Significant antifungal carryover (>25% reduction in CFU/milliliter from the control value) was observed with amphotericin B and fluconazole; however, carryover was eliminated with filtration. Agitation did not appreciably affect results. The starting inoculum did not significantly affect the activity of fluconazole or amphotericin B; however, the activity of LY303366 may be influenced by the starting inoculum. Before antifungal time-kill curve methods are routinely employed by investigators, methodology should be scrutinized and standardized procedures should be developed.Keywords
This publication has 7 references indexed in Scilit:
- Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformansJournal of Antimicrobial Chemotherapy, 1998
- Growth medium effect on the antifungal activity of LY 303366Diagnostic Microbiology and Infectious Disease, 1997
- Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicansAntimicrobial Agents and Chemotherapy, 1997
- In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsAntimicrobial Agents and Chemotherapy, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.Diagnostic Microbiology and Infectious Disease, 1996
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980